Brief introduction:

Guangzhou Haibt Medical Technology Co., LTD. (hereinafter referred to as "HaIBt"), founded in October 2009, is a well-known comprehensive CRO company focusing on providing clinical evaluation technical services. Its main business is: clinical trials of pharmaceutical products in various phases and post-listing clinical reevaluation technical services.

Sea bothe the existing professional and technical personnel more than 130 people, the number nine people or above, majoring in clinical medicine medical consulting and scientists adviser to 10 people, master's and a master's degree in accounting for the company for more than 50% of the total number of undergraduate and bachelor degree or above accounted for 90% of the company's total number of above, obtain GCP training certificates issued by the state food and drug administration personnel occupies total number in the company of more than 95%.

Our service products cover chemical medicine, Traditional Chinese medicine, biological products, medical devices, diagnostic reagents, health food, etc.

Services include: pediatrics, dermatology, acute, gastrointestinal, rehabilitation, general surgery, cardiology, cardiovascular division, ICU, oncology, intervention, endocrinology, gynecology, obstetrics and gynecology, reproductive medicine center, urology, respiratory, ophthalmology, orthopedics, neurology, and other multi-disciplinary various clinical trial project.

As the only company through the international ISO9001:2015 quality management system certification, localization of CRO company sea bothe adhering to the "hard for your medical career attentively the entire innovation value" of the enterprise mission, positioning precision in clinical trial scheme design, committed to the fine management of clinical trials, build CRO with efficient operation ability.

Aspire to be the CRO with the highest success rate of project application in the industry, and build the no.1 brand of clinical evaluation technology service for Pharmaceutical products in China.

In order to better serve customers across the country, timely grasp the trends of policies and regulations, contact overseas products, and help pharmaceutical enterprises to register and apply overseas, HaIBin has set up wholly-owned subsidiaries in Beijing and Hong Kong, which are Respectively Beijing Haibin Medical Research Co., Ltd. and HaIBin (China) Medical Clinical Evaluation Center.

Sea bothe always pay attention to the use and development tools, in the hope of a more scientific and effective management of clinical trials project implementation and the company's internal management, sea bothe started clinical research cloud data processing center, the introduction of EDC data management system, developed an exclusive copyright of CTMS project management system, the implementation of efficient electronic information management of clinical research outsourcing services.